RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제
      • 좁혀본 항목 보기순서

        • 원문유무
        • 원문제공처
        • 등재정보
        • 학술지명
        • 주제분류
        • 발행연도
        • 작성언어
        • 저자
          펼치기

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재후보

        말기 신부전증 환자에서의 B 형 간염 백신의 효과

        김종진(Jong Jin Kim),문미경(Mi Kyoung Moon),임학(Hark Rim),김진규(Jin Kyoou Kim),박선자(Seon Ja Park),양상호(Sang Ho Yang),박상은(Sang Eun Park),이시래(Si Rhae Lee) 대한내과학회 1991 대한내과학회지 Vol.41 No.2

        N/A The immune response to HB vaccination in ESRD patients has thus far been poor, but a better immune response is seen in patients who have been given reinforced vaccination. We measured anti-HBs seroconversion rates in a total of 100 ESRD patients (HD 60, CAPD 37, and transplantation 3 patients) who were vaccinated with Hepavax®. The results were as follows: 1) The anti-HBs seroconversion rate of 54 anti-HBc positive patients was 44.6%, and that of 46 anti-HBc negative patients 34.8%. 2) Anti-HBs seroconversion rates were 38.3% in the HD group, 43.2% in the CAPD group, and 33.3% in the renal transplantation group. 3) There was a lower anti-HBs seroconversion rate in the group under going a longer of dialysis: 44.4% in the group of less than 1 month period of dialysis and 9.1% in the group who had been on dialysis for 13 to 36 months. 4) Anti-HBs seroconversion rates were 39.1% in 40 ㎍, 3 times vaccination group, 45.6% in 20 ㎍, 3 times vaccination group, and 39.3% in 40 ㎍, 1 or 2 times vaccination group. The seroconverted patients in 40 ㎍, 3 times vaccination group revealed a higher titer and longer sustained anti-HBs in serum. However, anti-HBs seroconversion rates were not different in the 3 groups of various dosages. 5) An anti-HBc negative patient who had revealed low titer of anti-HBs after 3 doses of 20 ㎍, received a kindey transplantation from an HBsAg negative donor and developed acute viral hepatitis B in 10 months. Another anti-HBc positive patient, who had revealed a low titer of anti-HBs after 2 doses of 40 ㎍ but converted into anti-HBs negative in 5 months, showed a high titer of anti-HBs after receiving a renal transplantation from an HBsAg positive donor. These results show that reinforced doses of HB vaccine in ESRD patients were effective in developing a higher titer and longer duration of anti-HBs.

      • KCI등재후보

        담도암에 대한 임상적 고찰

        안수열,임학,문미경,최영식,차태준,서승연,구자영,박병채 대한내과학회 1992 대한내과학회지 Vol.42 No.2

        We assessed 79 cases of chloangiocarcinoma which was diagnosed histologically at Kosin General Hospital and Kim Hae Gospel Hospital from 1986 to 1990 and the results are as follows; 1) More than half of all patients were beyond sixth decade, the ratio of male to female was 2:l and 2.8:1 in intra and extrahepatic cholangiocarcinoma, respectively. 2) Prevalence rate of clonorchiasis was 30%, 18.4% in intrahepatic and extrahepatic cholangiocarcinoma, respectively, and prevalence rate of clonorchiasis in intrahepatic cholangiocarcinoma was markedly higher than that (19.6%) of general population in Pusan, Kyungnam area. 3) The predominant symptoms were general weakness (90.0%), abdominal pain (53.3%), jaundice (46.7%) in intrahepatic cholangiocarcinoma, and in extrahepatic cholangiocarcinoma, jaundice was the most frequent symptom (75.5%). 4) Of the 11 patients with distant metastases in in trahepatic cholangiocarcinoma, the most common site of metastases was abdominal lymph nodes (91 .O%) followed by liver (36.4%), peritoneum (27.3%) and kindey (18.2%). 5) Serum CEA level was more than 10ng/㎖ in 66.7% of intrahepatic cholangiocarcinoma and 26.5% of extrahepatic cholangiocarcinoma which suggested that serum CEA level may be more useful in the diagnosis of intrahepatic cholangiocarcinoma than extrahepatic cholangiocarcinoma. Serum CA 19-9 level was more than 37 U/㎖ in 80.0% of intrahepatic cholangiocarcinoma and 67.3% of extrahepatic cholangiocarcinoma. 6 ) Of the 11 patients with distant metastases in intrahepatic cholangiocarcinoma. 9 patients (81.8%) had serum CEA levels of more than 60ng/㎖, and 5 of 19 patients (26.3%) with localized tumor showed CEA levels of more than 60 ng/㎖, the difference between these two groups was statistically significant (p< 0.05).

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼